Genetic effects of estrogen receptor α and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in caucasian women

Metabolism: Clinical and Experimental

Volumn 52, Issue 9, 2003, Pages 1129-1135

  Sapir Koren, R ^a   Livshits, G ^a   Kobyliansky, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOCHEMICAL MARKER; COLLAGEN; COLLAGEN IA1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN C PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MINERAL; BONE TURNOVER; CANCELLOUS BONE; CAUCASIAN; CONTROLLED STUDY; CORTICAL BONE; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHENOTYPE; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE TYPES; VITAMIN BLOOD LEVEL;

EID: 0141794176     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00187-2     Document Type: Article

References (38)

1. Grant SFA, Reid DM, Blake G, et al: Reduced bone density and osteoporosis associated with a polymorphic SP1 binding site in the collagen type I α1 gene. Nat Genet 14:203-205, 1996
2. Keen RW, Woodford-Richens KL, Grant SFA, et al: Association of polymorphism at the type I collagen (COLIA1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 42:285-290, 1999
3. Uitterlinden AG, Weel AEAM, Burger H, et al: Interaction between the vitamin D receptor gene and collagen type Iα1 gene in susceptibility for fracture. J Bone Miner Res 16:379-385, 2001
4. Brown MA, Haughton MA, Grant SFA, et al: Genetic control of bone density and turnover: Role of the collagen Iα1, estrogen receptor, and vitamin D receptor genes. J Bone Miner Res 16:758-764, 2001
5. Kobayashi S, Inoue S, Hosoi T, et al: Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306-311, 1996
6. Han KO, Moon IG, Kang YS, et al: Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 82:991-995, 1997
7. Becherini L, Gennari L, Masi L, et al: Evidence of linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 9:2043-2050, 2000.
8. Albagha OME, McGuigan FEA, Reid DM, et al: Estrogen receptor α gene polymorphisms and bone mineral density: Haplotype analysis in women from the United Kingdom. J Bone Miner Res 16:128-134, 2001
9. Pacifici R: Cytokines, estrogen and postmenopausal osteoporosis - The second decade. Endocrinology 139:2659-2661, 1998
10. Gallagher JC, Kinyamu HK, Fowler SE, et al: Calciotropic hormones and bone makers in the elderly. J Bone Miner Res 13:475-482, 1998
11. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, et al: Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 49:803-809, 1998
12. Sapir-Koren R, Livshits G, Landsman T, et al: Bone mineral density is associated with estrogen receptor gene polymorphism in men. Anthrop Anz 59:343-353, 2001
13. Sapir-Koren R, Livshits G, Kobyliansky E: Association and linkage analysis suggest genetic effects of estrogen receptor α and collagen IA1 genes on bone mineral density in caucasian women. Calcif Tissue Int (in press) Online First Publications (Feb 2003) doi: 10.1007/S00223-002-2006-5
14. Lips P, Duong T, Oleksik A, et al: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212-1221, 2001
15. Gallagher LC: Patophysiology of osteoporosis. Semin Nephrol 12:109-115, 1992
16. Chapuy MC, Schott AM, Garnero P, et al: Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129-1133, 1996
17. Livshits G, Karasik D, Pavlovsky OM, et al: Segregation analysis reveals a major gene effect in compact and cancellous bone mineral density in two populations. Hum Biol 71:155-172, 1999
18. Livshits G, Karasik D, Kobyliansky E: Complex segregation analysis of the radiographic phalanges BMD and their age related changes. J Bone Miner Res 17:152-161, 2002
19. Livshits G, Pavlovsky OM, Kobyliansky E: Population biology of human aging: Segregation analysis of bone age characteristics. Hum Biol 68:539-544, 1996
20. Versluis R, Petri H, Vismans F, et al: The relationship between phalangeal bone density and vertebral deformities. Calcif Tissue Int 66:1-4, 2000
21. Livshits G, Yakovenko C, Kobyliansky E: Quantitative genetic analysis of circulating levels of biochemical markers of bone formation. Am J Med Genet 94:324-331, 2000
22. Gallagher JC, Riggs CL, DeLuca HF: Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51:1359-1364, 1980
23. Khosla S, Atiknson EJ, Melton J, et al: Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-base study. J Clin Endocrinol Metab 82:1522-1527, 1997
24. Heshmati HM, Khosla S, Robins SP, et al: Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 17:172-178, 2002
25. Naveh-Many T, Almogi G, Livni N, et al: Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest 90:2434-2438, 1992
26. Deng HW, Li J, Li JL, et al: Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen genotypes. Hum Genet 103:576-585, 1998
27. Ongphiphadhanakul B, Chanprasetryothin S, Payatikul P, et al: Oestrogen-receptor-alpha gene polymorphism affects responses in bone mineral density to oestrogen in postmenopausal women. Clin Endocrinol (Oxf) 52:581-585, 2000
28. Matsubara Y, Murata M, Kawano K, et al: Genotype distribution of estrogen receptor polymorphisms in and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17:3006-3112, 1997
29. Herrington DM, Howard TD, Hawkins GA, et al: Estrogen receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women coronary disease. N Engl J Med 346:967-974, 2002
30. Herrington DM, Howard TD, Brosnihan KB, et al: Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879-1882, 2002
31. De Leo V, Ditto A, La Marca A, et al: Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women. Calcif Tissue Int 66:263-267, 2000
32. Mann V, Hobson EE, Li B, et al.: A COLIA1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899-907, 2001
33. Waters KM, Rickard DJ, Riggs BL, et al: Estrogen regulation of human osteoblast function is determined by the stage differentiation and the estrogen receptor isoform. J Cell Biochem 83:448-462, 2001
34. Klinge CM: Estrogen receptor interaction with co-activators and co-repressors. Steroids 65:227-251, 2000
35. Krishnan V, Wang X, Safe S: Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917, 1994
36. Porter W, Wang F, Wang W, et al: Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10:1371-1378, 1996
37. Porter W, Saville B, Hoivic D, et al: Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580, 1997
38. Petz LN, Nardulli AM: Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 14:972-985, 2000